Kristan A Meetze (Kristan Meetze)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Human Serum Albumin

Single Molecule

Top Venues

Cancer immunology research

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Naveen K Mehta, Kavya Rakhra, Kristan A Meetze, Bochong Li, Noor Momin, Jason Y H Chang, Karl Dane Wittrup, Patrick A Baeuerle, Jennifer S Michaelson
CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity. Cancer immunology research 12 (8) (2024)
Naveen K Mehta, Kavya Rakhra, Kristan A Meetze, Bochong Li, Noor Momin, Jason Y H Chang, Karl Dane Wittrup, Patrick A Baeuerle, Jennifer S Michaelson
CLN-617 retains IL-2 and IL-12 in injected tumors to drive robust and systemic immune-mediated antitumor activity. Cancer immunology research (2024)
Naveen K Mehta, Kavya Rakhra, Kristan A Meetze, Bochong Li, Noor Momin, Jason Y H Chang, Karl Dane Wittrup, Patrick A Baeuerle, Jennifer S Michaelson
CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity. Cancer immunology research 12 (8) (2024)
Naveen K Mehta, Kavya Rakhra, Kristan A Meetze, Bochong Li, Noor Momin, Jason Y H Chang, Karl Dane Wittrup, Patrick A Baeuerle, Jennifer S Michaelson
CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity. Cancer immunology research 12 (8) (2024)
Kristan A Meetze, Naveen K Mehta, Bochong Li, Jennifer S Michaelson, Patrick A Baeuerle
CLN-978, a novel half-life extended CD19/CD3/HSA-specific T cell-engaging antibody construct with potent activity against B-cell malignancies with low CD19 expression. Journal for immunotherapy of cancer 11 (8) (2023)